Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.01 USD | +0.25% | -66.91% | -50.49% |
05-28 | RBC Halves Price Target on Verastem to $16 From $32, Maintains Outperform Rating, Speculative Risk Qualifier | MT |
05-24 | Top Midday Decliners | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.49% | 101M | |
+8.12% | 114B | |
+9.27% | 104B | |
-1.40% | 22.57B | |
-11.67% | 22.5B | |
-10.23% | 17.95B | |
-41.90% | 16.48B | |
-14.49% | 15.82B | |
+3.25% | 13.55B | |
+28.05% | 10.99B |
- Stock Market
- Equities
- VSTM Stock
- News Verastem, Inc.
- Transcript : Verastem, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-10-2019 11